Search

Robert M Fetsuga

Examiner (ID: 1858, Phone: (571)272-4886 , Office: P/3993 )

Most Active Art Unit
3751
Art Unit(s)
2899, 2403, 3751, 3993, 1751, 3105
Total Applications
2201
Issued Applications
1476
Pending Applications
73
Abandoned Applications
652

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8756044 [patent_doc_number] => 20130090349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist' [patent_app_type] => utility [patent_app_number] => 13/645595 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 27603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13645595 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/645595
Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist Oct 4, 2012 Abandoned
Array ( [id] => 8767144 [patent_doc_number] => 20130095181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/646130 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29243 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646130 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/646130
PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF Oct 4, 2012 Abandoned
Array ( [id] => 11176937 [patent_doc_number] => 09408913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Composition and dressing for wound treatment' [patent_app_type] => utility [patent_app_number] => 14/344403 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7763 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344403 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344403
Composition and dressing for wound treatment Sep 11, 2012 Issued
Array ( [id] => 9831850 [patent_doc_number] => 08940662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Methods for controlling pests' [patent_app_type] => utility [patent_app_number] => 13/607249 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13607249 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/607249
Methods for controlling pests Sep 6, 2012 Issued
Array ( [id] => 8683955 [patent_doc_number] => 20130052239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Formulation' [patent_app_type] => utility [patent_app_number] => 13/602735 [patent_app_country] => US [patent_app_date] => 2012-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17754 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602735 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/602735
Formulation Sep 3, 2012 Abandoned
Array ( [id] => 8522276 [patent_doc_number] => 20120321684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Color Cosmetic' [patent_app_type] => utility [patent_app_number] => 13/597154 [patent_app_country] => US [patent_app_date] => 2012-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3445 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597154 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/597154
Color Cosmetic Aug 27, 2012 Abandoned
Array ( [id] => 10380517 [patent_doc_number] => 20150265524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'NAIL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/416438 [patent_app_country] => US [patent_app_date] => 2012-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8089 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416438 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/416438
NAIL COMPOSITIONS Aug 15, 2012 Abandoned
Array ( [id] => 9843682 [patent_doc_number] => 08945593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Orally ingested metabolic enhancer in oral thin film container' [patent_app_type] => utility [patent_app_number] => 13/565903 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2731 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13565903 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/565903
Orally ingested metabolic enhancer in oral thin film container Aug 2, 2012 Issued
Array ( [id] => 9736169 [patent_doc_number] => 20140271881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'ANTISEPTIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/234193 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4106 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234193 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/234193
ANTISEPTIC COMPOSITION Aug 1, 2012 Abandoned
Array ( [id] => 8495531 [patent_doc_number] => 20120294939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'DIRECT COMPRESSION FORMULATION AND PROCESS' [patent_app_type] => utility [patent_app_number] => 13/562415 [patent_app_country] => US [patent_app_date] => 2012-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13875 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562415 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/562415
DIRECT COMPRESSION FORMULATION AND PROCESS Jul 30, 2012 Abandoned
Array ( [id] => 8585830 [patent_doc_number] => 20130004651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS' [patent_app_type] => utility [patent_app_number] => 13/560730 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6142 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560730 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/560730
SUSTAINED DRUG RELEASE FROM BODY IMPLANTS USING NANOPARTICLE-EMBEDDED POLYMERIC COATING MATERIALS Jul 26, 2012 Abandoned
Array ( [id] => 8940544 [patent_doc_number] => 20130190341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'HIGH BIOAVAILABILITY OPIOID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/558463 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19017 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558463 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/558463
HIGH BIOAVAILABILITY OPIOID FORMULATIONS Jul 25, 2012 Abandoned
Array ( [id] => 8477871 [patent_doc_number] => 20120277278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'PHENYLBUTAZONE CARRIER FORMULATION SHOWING INCREASED BIOACTIVITY IN ANIMALS' [patent_app_type] => utility [patent_app_number] => 13/543948 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4935 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543948 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/543948
Phenylbutazone carrier formulation showing increased bioactivity in animals Jul 8, 2012 Issued
Array ( [id] => 8464605 [patent_doc_number] => 20120269772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'LIPID DEPOT FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/537096 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18416 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13537096 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/537096
Lipid depot formulations Jun 28, 2012 Issued
Array ( [id] => 8708681 [patent_doc_number] => 20130065970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'COMPOSITIONS AND PRODUCTS CONTAINING ESTOLIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/534424 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20032 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534424 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/534424
COMPOSITIONS AND PRODUCTS CONTAINING ESTOLIDE COMPOUNDS Jun 26, 2012 Abandoned
Array ( [id] => 9490652 [patent_doc_number] => 20140141057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'Adhesive or Hydrocolloid Containing Vegetable Oil' [patent_app_type] => utility [patent_app_number] => 14/128658 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5502 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128658 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/128658
Adhesive or Hydrocolloid Containing Vegetable Oil Jun 18, 2012 Abandoned
Array ( [id] => 8370233 [patent_doc_number] => 20120219622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'DPP IV INHIBITOR FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/467505 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3729 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467505 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/467505
DPP IV INHIBITOR FORMULATIONS May 8, 2012 Abandoned
Array ( [id] => 9615701 [patent_doc_number] => 20140205559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND NAILS' [patent_app_type] => utility [patent_app_number] => 14/116360 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26966 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116360 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116360
Antifungal compositions for the treatment of skin and nails May 7, 2012 Issued
Array ( [id] => 8696937 [patent_doc_number] => 20130058946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'Seizure and Migraine Treatments using Denosumab' [patent_app_type] => utility [patent_app_number] => 13/462661 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25839 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462661 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462661
Seizure and Migraine Treatments using Denosumab May 1, 2012 Abandoned
Array ( [id] => 8359717 [patent_doc_number] => 20120214876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet' [patent_app_type] => utility [patent_app_number] => 13/462320 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25833 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462320 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/462320
Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet May 1, 2012 Abandoned
Menu